Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic cats

Archives of Virology

Volumn 142, Issue 12, 1997, Pages 2389-2400

  Weigler, B J ^a,c   Guy, J S ^a   Nasisse, M P ^b   Hancock, S I ^a   Sherry, B ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031460047     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050250     Document Type: Article

References (35)

1. Bourne N, Stanberry LR, Bernstein DI, Lew D (1996) DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 173: 800-807
2. Cocker FM, Gaskell RM, Newby TJ, Gaskell CJ, Stokes CR, Bourne FJ (1983) Efficacy of early (48 and 96 hour) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant. Vet Rec 114: 353-354
3. Cocker FM, Newby TJ, Gaskell RM, Evans PA, Gaskell CJ, Stokes CR, Harbour DA, Bourne FJ (1986) Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1. Res Vet Sci 41: 323-330
4. Davis EV, Beckenhauer WH (1976) Studies on the safety and efficacy of an intranasal feline rhinotracheitis-calici virus vaccine. Vet Med Small Anim Clin 71: 1405-1410
5. Dawson S, Gaskell RM (1993) Problems with respiratory virus vaccination in cats. Comp Contin Educ Pract Vet 15: 1347-1354
6. Fleiss JL (1981) Statistical methods for rates and proportions, 2nd ed. John Wiley & Sons, New York
7. Galeota JA, Flores EF, Kit S, Kit M, Osorio FA (1997) A quantitative study of the efficacy of a deletion mutant bovine herpesvirus-1 differential vaccine in reducing the establishment of latency by wildtype virus. Vaccine 15: 123-128
8. Gaskell RM, Povey RC (1979) Feline viral rhinotracheitis: sites of virus replication and persistence in acutely and persistently infected cats. Res Vet Sci 27: 167-174
9. Gaskell RM, Dennis PE, Goddard LE, Cocker FM, Wills JM (1985) Isolation of felid herpesvirus 1 from the trigeminal ganglia of latently infected cats. J Gen Virol 66: 391-394
10. Gaskell RM, Dawson S (1994) Viral-induced upper respiratory tract disease. In: Chandler EA, Gaskell CJ, Gaskell RM (eds) Feline medicine and therapeutics. Blackwell Scientific, Oxford, pp 453-472
11. - deletion mutant in the natural host. Virology 220: 299-308
12. Morein B, Merza M (1991) Vaccination against herpesvirus, fiction or reality? Scand J Infect [Suppl] 78: 110-118
13. Nasisse MP, Guy JS, Davidson MG, Sussman WA, Fairley NM (1989) Experimental ocular herpesvirus infection in the cat. Invest Opthalmol Vis Sci 30: 1 758-1 768
14. Nasisse MP, Davis BJ, Guy JS, Davidson MG, Sussman W (1992) Isolation of feline herpesvirus 1 from the trigeminal ganglia of acutely and chronically infected cats. J Vet Intern Med 6: 102-103
15. Nasisse MP, Weigler BJ (1997) The diagnosis of ocular feline herpesvirus infection. Vet Comp Ophthalmol 7: 44-51
16. Nunberg JH, Wright DK, Cole GE, Petrovskis EA, Post LE, Compton T, Gilbert JH (1989) Identification of the thymidine kinase gene of feline herpesvirus: use of degenerate oligonucleotides in the polymerase chain reaction to isolate herpesvirus gene homologs. J Virol 63: 3240-3249
17. O'Brien WJ, Taylor JL (1989) The isolation of herpes simplex virus from rabbit corneas during latency. Invest Ophthalmol Vis Sci 30: 357-364
18. Ohmura Y, Ono E, Matsuura T, Kida H, Shimizu Y (1993) Detection of feline herpesvirus 1 transcripts in trigeminal ganglia of latently infected cats. Arch Virol 129: 341-347
19. Orr CM, Gaskell CJ (1978) Interaction of a combined feline viral rhinotracheitis-feline calicivirus vaccine and the FVR carrier state. Vet Rec 103: 200-202
20. Orr CM, Gaskell CJ (1980) Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state. Vet Rec 106: 164-166
21. L15 open reading frame of herpes simplex virus 1. J Virol 67: 4497-4503
22. Povey RC, Johnson RH (1971) A survey of feline viral rhinotracheitis and feline picornavirus infection in Britain. J Small Anim Pract 12: 233-247
23. Reubel GH, Ramos RA, Hickman MA, Rimstad E, Hoffmann DE, Pedersen NC (1993) Detection of active and latent feline herpesvirus 1 infections using the polymerase chain reaction. Arch Virol 132: 409-420
24. Kiyono H, Ogra PL, McGhee JR (1996) Mucosal vaccines. Academic Press, San Diego
25. Rota PA, Maes RK, Ruyechan WT (1986) Physical characterization of the genome of feline herpesvirus-1. Virology 154: 168-179
26. Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, New York
27. Schoenbaum MA, Beran GW, Murphy DP (1990) Pseudorabies virus latency and reactivation in vaccinated swine. Am J Vet Res 51: 334-338
28. Slater E, York C (1976) Comparative studies on parenteral and intranasal inoculation of an attenuated feline herpes virus. Dev Biol Standard 33: 410-416
29. Stiles J, McDermott M, Bigsby D, Willis M, Martin C, Roberts W, Greene C (1997) Use of nested polymerase chain reaction to identify feline herpesvirus in ocular tissue from clinically normal cats and cats with corneal sequestra or conjunctivitis. Am J Vet Res 58: 338-342
30. Sussman MD, Maes RK, Kruger JM (1997) Vaccination of cats for feline rhinotracheitis results in a quantitative reduction of virulent feline herpesvirus-1 latency load after challenge. Virology 228: 379-382
31. Sykes JE, Browning GF, Anderson G, Studdert VP, Smith HV (1997) Differential sensitivity of culture and the polymerase chain reaction for detection of feline herpesvirus 1 in vaccinated and unvaccinated cats. Arch Virol 142: 65-74
32. Weigler BJ, Babineau CA, Sherry B, Nasisse MP (1997) High sensitivity polymerase chain reaction assay for active and latent feline herpesvirus-1 infections in domestic cats. Vet Rec 140: 335-338
33. Wilson JHG (1978) Intranasal vaccination against upper respiratory tract disease (URD) in the cat. II. Results of field studies under enzootic conditions in the Netherlands with a combined vaccine containing live attenuated calici-and herpesvirus. Comp Immunol Microbiol Infect Dis 1: 43-48
34. Yokoyama N, Maeda K, Tohya Y, Kawaguchi Y, Shin Y-S, Ono M, Ishiguro S, Fujikawa Y, Mikami T (1996) Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats. Arch Virol 141: 481-494
35. Yokoyama N, Maeda K, Fujita K, Ishiguro S, Sagawa T, Mochizuki K, Tohya Y, Mikami T (1996) Vaccine efficacy of a recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats. Arch Virol 141: 2339-2351